A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT07287644. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Dose Ranging, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of BFB759 in Patients With Moderate to Severe Hidradenitis Suppurativa
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a double-blind, placebo-controlled study where subjects are participating for approximately 36 to 40 weeks. The study compares how well BFB759 works and how safe it is compared with a placebo.
Study identification
- NCT ID
- NCT07287644
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Enrollment
- 210 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 3, 2025 (Actual)
- Primary completion
- Aug 1, 2027 (Estimated)
- Completion
- Aug 1, 2027 (Estimated)
- Last update posted
- Oct 14, 2026
2025 – 2027
United States locations
- U.S. sites
- 35
- U.S. states
- 18
- U.S. cities
- 35
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Saguaro Dermatology | Phoenix | Arizona | 85008 | — |
| Encino Research Center | Encino | California | 91436 | — |
| Marvel Clinical Research LLC | Huntington Beach | California | 92647 | — |
| Clinical Science Institute | Santa Monica | California | 90404 | — |
| Skin Care Research | Boca Raton | Florida | 33021 | — |
| Center for Skin Science and Innovation | Fort Lauderdale | Florida | 33308 | — |
| Gsi Clinical Research | Margate | Florida | 33063 | — |
| Ziaderm Research LLC | North Miami Beach | Florida | 33126 | — |
| Clinical Trials Management, LLC | Tampa | Florida | 33607 | — |
| DelRicht Research | Atlanta | Georgia | 30329 | — |
| Southeast Research Specialist LLC | Douglasville | Georgia | 30135 | — |
| The Indiana Clinical Trials Center, PC | Plainfield | Indiana | 46168 | — |
| DS Research of Kentucky | Louisville | Kentucky | 40241 | — |
| Martha Stewart | Mandeville | Louisiana | 70448 | — |
| Clinical Trials Management, LLC | Metairie | Louisiana | 70006 | — |
| DelRicht Research | New Orleans | Louisiana | 70115 | — |
| Oakland Hills Dermatology | Auburn Hills | Michigan | 48326 | — |
| MI Skin Innovations | Northville | Michigan | 48167 | — |
| DelRicht Research | Wildwood | Missouri | 63040 | — |
| JDR Dermatology Research LLC | Las Vegas | Nevada | 89145 | — |
| Skin Cancer and Dermatology Institute | Reno | Nevada | 89509 | — |
| Schweiger Dermatology, PC | Hackensack | New Jersey | 07601 | — |
| Equity Medical LLC | The Bronx | New York | 10455 | — |
| Optima Research - Boardman | Boardman | Ohio | 44512 | — |
| Apex Clinical Research Center, LLC | Canton | Ohio | 44718 | — |
| Apex Clinical Research Center, LLC | Mayfield Heights | Ohio | 44124 | — |
| UPMC Department of Dermatology | Pittsburgh | Pennsylvania | 15213 | — |
| Medical Univ of SC Department of Dermatology | Charleston | South Carolina | 29425 | — |
| DelRicht Research | Mt. Pleasant | South Carolina | 29464 | — |
| DelRicht Research | Smyrna | Tennessee | 37167 | — |
| Dermatology Treatment & Research Center | Dallas | Texas | 75230 | — |
| VAST Clinical Research LLC | Frisco | Texas | 75033 | — |
| DelRicht Research | Prosper | Texas | 75078 | — |
| Stryde Research-Epiphany Dermatology | Southlake | Texas | 76092 | — |
| Dermatology Specialists of Spokane | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 29 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07287644, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 14, 2026 · Synced Nov 14, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.